UNSPSC 51184003: Chlorpropamide

This classification denotes an anti-diabetic agent with the molecular formula C10H13ClN2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) WTM2C3IL2X, chemically known as urea, 1-((p-chlorophenyl)sulfonyl)-3-propyl- but more generally known as chlorpropamide, which bears US NIH Compound Identifier 2727. European Medicines Agency schedules Chlorpropamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06209MIG.

UNSPSC 51184003 Chlorpropamide is a Commodity code covering specific pharmaceutical active ingredients procured by state and local health systems, pharmacy benefit managers, and cooperative purchasing alliances. State and local governments buy this code primarily as part of broader generic drug procurement contracts that bundle multiple pharmaceutical products for distribution across participating facilities. The issuing bodies include state departments of administration, regional and multistate cooperative purchasing alliances, and their member jurisdictions spanning state health agencies, local health departments, and institutional pharmacy networks. Work under this code involves supplying pharmaceuticals through authorized wholesale distributors under negotiated pricing agreements that specify National Drug Codes (NDCs), dosage forms, packaging configurations, and manufacturing locations, with vendors required to maintain compliance certifications including current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA).

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued a Request for Proposal on January 20, 2026 (S1070000015802) to establish multiple contracts for generic multi-source pharmaceuticals and over-the-counter products with response due March 26, 2026. The RFP covers participating facilities in Minnesota and Oregon and requires vendors to supply products through three authorized wholesalers: AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC. Evaluation weights pricing competitiveness at 75 percent, fixed pricing at 10 percent, and compliance with administrative format and EDI capability each at 5 percent; vendors must carry commercial general liability insurance of $5,000,000 per occurrence and network security and privacy liability of $2,000,000, with the contract term two years for new responders and optional extensions at MMCAP's discretion, effective July 1, 2026.